Carboplatin

Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study

Palliative Care / Quality of life / Survival Analysis / Treatment Outcome / Risk assessment / Probability / Spain / Humans / Female / Confidence intervals / Paclitaxel / Aged / Middle Aged / Combination chemotherapy / Adult / Prognosis / Ovarian Carcinoma / Randomized Clinical Trial / Risk Assessment / Annals / Area Under the Curve / Overall Survival / Confidence Interval / Carboplatin / Ovariectomy / Phase II Trial / Probability / Spain / Humans / Female / Confidence intervals / Paclitaxel / Aged / Middle Aged / Combination chemotherapy / Adult / Prognosis / Ovarian Carcinoma / Randomized Clinical Trial / Risk Assessment / Annals / Area Under the Curve / Overall Survival / Confidence Interval / Carboplatin / Ovariectomy / Phase II Trial

A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)

Research Design / Quality of life / Japan / Humans / Female / Follow-up studies / Paclitaxel / Recurrence / Cisplatin / Clinical Protocols / Antineoplastic Agents / Carboplatin / Follow-up studies / Paclitaxel / Recurrence / Cisplatin / Clinical Protocols / Antineoplastic Agents / Carboplatin

Resultados oncológicos y funcionales del tratamiento no quirúrgico comparado con el quirúrgico en los carcinomas epidermoides de orofaringe

Quality of life / Treatment Outcome / Humans / Female / Male / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy

Resultados oncológicos y funcionales del tratamiento no quirúrgico comparado con el quirúrgico en los carcinomas epidermoides de orofaringe

Quality of life / Treatment Outcome / Humans / Female / Male / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy

Resultados oncológicos y funcionales del tratamiento no quirúrgico comparado con el quirúrgico en los carcinomas epidermoides de orofaringe

Quality of life / Treatment Outcome / Humans / Female / Male / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy / Follow-up studies / Monoclonal Antibodies / Risk factors / Clinical Sciences / Cisplatin / Middle Aged / Oral Squamous Cell Carcinoma (OSCC) / Retrospective Studies / Prognosis / Risk Factors / Antineoplastic Agents / Enteral Nutrition / Carboplatin / Combined Modality Therapy

Copyright © 2017 DATOSPDF Inc.